Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™

Recruiting Observational Study
Mouth Diseases
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
180 (estimated)
Sponsor
Proteocyte Diagnostics Inc. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to validate the ability of the STRATICYTE™ predictive model to predict the transformation of oral potentially malignant disorders (OPMDs) to oral squamous cell carcinoma (OSCC) in a retrospective cohort of patients who received biopsies.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * From the archive, any patient who presents with clinically evident oral lesions and biopsy-proven dysplasia (punch or scalpel biopsies; any grade or classification system) * Patients with initial oral lesions with epithelial atypia suspicious for neoplasia, with: * No histolog…
Contacts

Jody Filkowski, BSc, MSc, PhD

1-825-305-0749

Jody.Filkowski@medlior.com

CONTACT

Jason TK Hwang, HBSc, MSc, PhD

1-647-255-1370

jhwang@proteocyte.com

CONTACT